Home » Authors » Omar Ford

Articles by Omar Ford

Simulation: unproven, costly but beginning to gain traction

Oct. 25, 2007

ExThera formed to treat sepsis as latest device/drug matchup

Oct. 22, 2007

Virtual Companies Project used to boost Michigan's economy

Oct. 16, 2007

In $42M buy, QLT has ForSight to address glaucoma patients

Oct. 10, 2007

Apollo in ‘A’ $11.5 million round; Simplex Diabetic garners $50M

Oct. 9, 2007

Panelist: ‘Focus’ essential for medical device start ups

Oct. 8, 2007

Med-tech landscape is sunny, but watch out for ‘storm clouds’

Oct. 5, 2007

Spectranetics launches PATENT trial for SFA instent restenosis

Oct. 3, 2007

Calcification attack, but adjacent tissue safety via Diamondback

Oct. 1, 2007

Product briefs: Digital Health wins PMA for Retasure retinopathy detection

Oct. 1, 2007

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...